logo
  • Home
  • News
Menu

Why RedHill Biopharma Stock Is Getting Crushed Today

Home / Stock Analysis / Why RedHill Biopharma Stock Is Getting Crushed Today
Article feature image

Why RedHill Biopharma Stock Is Getting Crushed Today

14 Sep Stock Analysis

What happened
Shares of the specialty biopharmaceutical company RedHill Biopharma(NASDAQ:RDHL) are down by an eye-popping 33% as of 10:53 a.m. EDT Tuesday morning. The drugmaker’s stock is tanking today in response to the performance of opaganib, a sphingosine…

Click here to view the original article.

Tags:
Global, Motley Fool
Facebook Google+ Twitter Pinterest
  Previous
Next  

Related Posts

Mask-Group-67_1764126265239_1764126272024.jpg
+

Excelsoft Technologies share price LIVE Updates: Stock slips below listing price; should you buy, sell or hold?

26 Nov Stock Analysis
Adani_enterprises_rights_issue_1764126670400_1764126670569.JPG
+

Adani Enterprises rights issue opens: Price, entitlement ratio, other important details in 10 points

26 Nov Stock Analysis

recent post

  • 69269aeaf0cbed7f46117046_69269ae9f703437a4c886508_lastImage.png

    The Future of Crypto: Investment Trends

    Nov 26 2025
  • Mask-Group-67_1764126265239_1764126272024.jpg

    Excelsoft Technologies share price LIVE Updates:

    Nov 26 2025
  • 69267d8f68dfc54415d89836_69267d8ec28911738bc4ebd6_lastImage.png

    What’s Ark Invest’s Game Plan in

    Nov 26 2025
  • Adani_enterprises_rights_issue_1764126670400_1764126670569.JPG

    Adani Enterprises rights issue opens: Price,

    Nov 26 2025
  • 6926808a09ac6576a356476d_69268089364a5abdb119b430_lastImage.png

    What’s Next for Crypto Trading in

    Nov 26 2025

Categories

  • Business
  • Crypto News
  • Investing Strategy
  • People
  • Stock Analysis

©2019.  All Rights Reserved.